Literature DB >> 33106315

Biochemical Transformation of Bacterial Lipopolysaccharide by acyloxyacyl hydrolase reduces host injury and promotes recovery.

Robert S Munford1, Jerrold P Weiss2, Mingfang Lu3.   

Abstract

Animals can sense the presence of microbes in their tissues and mobilize their own defenses by recognizing and responding to conserved microbial structures (often called Microbe-Associated Molecular Patterns or "MAMPs").  Successful host defenses may kill the invaders, yet the host animal may fail to restore homeostasis if the stimulatory microbial structures are not silenced.  Although mice have many mechanisms for limiting their responses to lipopolysaccharide (LPS), a major Gram-negative bacterial MAMP, a highly conserved host lipase is required to extinguish LPS sensing in tissues and restore homeostasis.   We review recent progress in understanding how this enzyme, acyloxyacyl hydrolase (AOAH), transforms LPS from stimulus to inhibitor, reduces tissue injury and death from infection, prevents prolonged post-infection immunosuppression, and keeps stimulatory LPS from entering the bloodstream.  We also discuss how AOAH may increase sensitivity to pulmonary allergens.   Better appreciation of how host enzymes modify LPS and other MAMPs may help prevent tissue injury and hasten recovery from infection. Published under license by The American Society for Biochemistry and Molecular Biology, Inc.

Keywords:  AOAH; CD14; Toll-like receptor 4 (TLR4); acyloxyacyl hydrolase; colitis; inflammation; lipid A; lipopolysaccharide (LPS); macrophage; natural killer cells (NK cells); tolerance

Year:  2020        PMID: 33106315     DOI: 10.1074/jbc.REV120.015254

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  112 in total

Review 1.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

Review 2.  Source control in the management of sepsis.

Authors:  M F Jimenez; J C Marshall
Journal:  Intensive Care Med       Date:  2001       Impact factor: 17.440

3.  Deacylation of structurally diverse lipopolysaccharides by human acyloxyacyl hydrolase.

Authors:  A L Erwin; R S Munford
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

4.  Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages.

Authors:  A A Peterson; R S Munford
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

5.  Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides.

Authors:  R S Munford; C L Hall
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

6.  Expression and characterization of recombinant human acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides.

Authors:  F S Hagen; F J Grant; J L Kuijper; C A Slaughter; C R Moomaw; K Orth; P J O'Hara; R S Munford
Journal:  Biochemistry       Date:  1991-08-27       Impact factor: 3.162

Review 7.  The structure and function of Francisella lipopolysaccharide.

Authors:  John S Gunn; Robert K Ernst
Journal:  Ann N Y Acad Sci       Date:  2007-03-29       Impact factor: 5.691

8.  Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunity.

Authors:  Brian M Janelsins; Mingfang Lu; Sandip K Datta
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

9.  Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway.

Authors:  R L Kitchens; R S Munford
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

10.  APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.

Authors:  J I Vélez; F Lopera; D Sepulveda-Falla; H R Patel; A S Johar; A Chuah; C Tobón; D Rivera; A Villegas; Y Cai; K Peng; R Arkell; F X Castellanos; S J Andrews; M F Silva Lara; P K Creagh; S Easteal; J de Leon; M L Wong; J Licinio; C A Mastronardi; M Arcos-Burgos
Journal:  Mol Psychiatry       Date:  2015-12-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.